Ventilator associated pneumoniaUnderstanding epidemiology and pathogenesis to guide prevention and empiric therapy ScienceDirect LOSTVAPE URSA Nano Cartridge 0.6 0.8 ohm SmoklePh VENTILATOR = LIFE SUPPORT but also VAP RISK. Up to 20% of ventilated patients >48 hrs develop VAP. Mortality? Can reach 50%. Here's what actually matters in ICU rounds VAP pathophysiology: the ETT related injury. The ETT has a crucial role Download Scientific Diagram